Loading
Medicure Inc. Stock: price and insider trades · Canada
Medicure Inc.: what insiders have been doing
Medicure Inc., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SEDI. The last twelve months, up to 21 October 2026, brought 6 filings signed by 2 insiders.
Every open-market trade in the period is a purchase: 5 purchases worth €16k, from 1 insider, and not a single sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. One trade stands out by size: a purchase of €12k from Friesen, Albert David, disclosed on 22 June 2026. Among those who bought: 1 senior executive.
The most recent open-market purchase was published on 23 June 2026, 120 days ago. Filings reach the SEDI feed a median of 2 days after the trade. That lag is the time during which only the insider knows about the trade.
Compared with its exchange (2,474 companies, median 12 filings), a count of 6 filings is below the norm. Looking back to 2016, when coverage begins, insiders filed 106 purchases and 6 sales.
For comparison within the same sector, see the insider buying recorded at Xenon Pharmaceuticals Inc. and Vivos Inc. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Insider Decl.
170
Thresholds
n/a
Buy Volume
€439,188
106 ops. · all time
Sell Volume
€217,611
6 ops. · all time
Who traded when
BuySaleAlbert David Friesen5 buys
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 23,011 of 26,280 companies
24.3
score / 100
Value23
Quality26
FCF yld-1.2%
Earn yld-15%
EV/EBITDA·
ROE-50%
Gross mgn41%
Net mgn-25%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CA$4.40
Analyst consensus
Income statement
RevenueCA$28.9M
Gross profitCA$11.7M41% margin
EBITDA-CA$4.2M-15% margin
Net income-CA$7.1M-23.2% margin
Valuation
P/Book4.0x
Beta1.15
Balance sheet & cash
Market capCA$45.9M
Total debtCA$891k
Free Cash Flow-CA$560k
Debt / Equity6%
Profitability & ownership
ROE-49.9%
ROA-17.8%
% insiders27.3%
% institutions23.1%
Last declaration on 5 August 2026
Declarations170 total
20,000 shares@ CA$1.100.079% mcap100.0% of flowOptionsTSXSEDI:4759144
2,500 shares@ CA$1.2511.8% of flowCommon SharesTSXSEDI:4738983
Canonical exit: 20 Sept 2026 (T+90)
200 shares@ CA$1.200.9% of flowCommon SharesTSXSEDI:4738982
Canonical exit: 20 Sept 2026 (T+90)
1,000 shares@ CA$1.234.6% of flowCommon SharesTSXSEDI:4738980
Canonical exit: 20 Sept 2026 (T+90)
2,000 shares@ CA$1.229.2% of flowCommon SharesTSXSEDI:4738382
Canonical exit: 17 Sept 2026 (T+90)
16,300 shares@ CA$1.2073.5% of flowCommon SharesTSXSEDI:4738380
Canonical exit: 17 Sept 2026 (T+90)
10,000 shares@ CA$1.050.4% of flowCommon SharesTSXSEDI:4322595
Canonical exit: 29 Aug 2024 (T+90)
10,000 shares@ CA$1.050.4% of flowCommon SharesTSXSEDI:4322597
Canonical exit: 1 Sept 2024 (T+90)
130,000 shares@ CA$1.407.6% of flowCommon SharesTSXSEDI:4243800
45,000 shares@ CA$0.30100.0% of flowCommon SharesTSXSEDI:4138744
45,000 shares@ CA$0.3097.2% of flowCommon SharesTSXSEDI:4138751
100 shares@ CA$1.300.0% of flowCommon SharesTSXSEDI:4120580
Canonical exit: 20 Jul 2023 (T+90)
3,900 shares@ CA$1.300.2% of flowCommon SharesTSXSEDI:4120581
Canonical exit: 26 Jul 2023 (T+90)
1,000 shares@ CA$1.300.1% of flowCommon SharesTSXSEDI:4118490
Canonical exit: 19 Jul 2023 (T+90)
1,000 shares@ CA$1.250.0% of flowCommon SharesTSXSEDI:4116416
Canonical exit: 13 Jul 2023 (T+90)
5,000 shares@ CA$1.300.3% of flowCommon SharesTSXSEDI:4115630
Canonical exit: 12 Jul 2023 (T+90)
5,000 shares@ CA$1.250.2% of flowCommon SharesTSXSEDI:4115629
Canonical exit: 12 Jul 2023 (T+90)
4,400 shares@ CA$1.1263.8% of flowCommon SharesTSXSEDI:4059435
Canonical exit: 6 Apr 2023 (T+90)
15,000 shares@ CA$1.200.7% of flowCommon SharesTSXSEDI:3949768
Canonical exit: 22 Aug 2022 (T+90)
200 shares@ CA$1.200.0% of flowCommon SharesTSXSEDI:3947677
Canonical exit: 16 Aug 2022 (T+90)
3,000 shares@ CA$1.200.1% of flowCommon SharesTSXSEDI:3946086
Canonical exit: 14 Aug 2022 (T+90)
1,000 shares@ CA$1.200.0% of flowCommon SharesTSXSEDI:3945404
Canonical exit: 11 Aug 2022 (T+90)
200 shares@ CA$1.200.0% of flowCommon SharesTSXSEDI:3945403
Canonical exit: 9 Aug 2022 (T+90)
2,500 shares@ CA$1.10Common SharesTSXSEDI:3939295
Canonical exit: 1 Aug 2022 (T+90)
1,100 shares@ CA$1.000.0% of flowCommon SharesTSXSEDI:3902369
Canonical exit: 5 Jun 2022 (T+90)
25 of 170 declarations
About Medicure Inc.
Medicure Inc. is a biopharmaceutical company focused on developing treatments for cardiovascular diseases. It is listed on the XTSE market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
